oppCDC-RFA-EH18-1806-cfda93.197-cidCDC-RFA-EH18-1806-instructions.pdf

Centers for Disease Control

National Center for Environmental Health

Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning

Prevention and Surveillance of Blood Lead Levels in Children

CDC-RFA-EH18-1806

Application Due Date: 08/09/2018

Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning

Prevention and Surveillance of Blood Lead Levels in Children

CDC-RFA-EH18-1806

TABLE OF CONTENTS

Part I. Overview Information A. Federal Agency Name B. Funding Opportunity Title C. Announcement Type D. Agency Funding Opportunity Number E. Catalog of Federal Domestic Assistance (CFDA) Number F. Dates G. Executive Summary

Part II. Full Text A. Funding Opportunity Description B. Award Information C. Eligibility Information D. Application and Submission Information E. Review and Selection Process F. Award Administration Information G. Agency Contacts H. Other Information I. Glossary

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-EH18-1806. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning Prevention and Surveillance of Blood Lead Levels in Children C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https ://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.

Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-EH18-1806

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.197 F. Dates:

1. Due Date for Letter of Intent (LOI): N/A

2. Due Date for Applications: 08/09/2018, 11:59 p.m. U.S. Eastern

Standard Time, at www.grants.gov.

3. Date for Informational Conference Call:

An informational conference call will occur on Tuesday, July 17, 2018, from 2 to 3 p.m. eastern standard time. Call-in information is 855-644-0229, conference ID 6530827 Updated details about the informational call will be posted at: https://www.cdc.gov/nceh/lead/

G. Executive Summary:

1. Summary Paragraph:

The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2018 funds that will be awarded through cooperative agreements to support childhood lead poisoning prevention activities including: blood lead testing, surveillance, and targeted population-based interventions. In addition, as part of this Notice of Funding Opportunity (NOFO), recipients will be expected to demonstrate that processes are in place to identify lead-exposed children and link them to recommended services. More specifically, recipients will be https://www.grants.gov https://www.grants.gov https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf https://www.grants.gov expected to work closely with other agencies, partners, other stakeholders serving children to ensure that a comprehensive system of referral, follow-up and evaluation is in place for lead-exposed children.

a. Eligible Applicants: Limited

b. NOFO Type: Cooperative Agreement

c. Approximate Number of Awards: 10

d. Total Period of Performance Funding: $10,000,000

e. Average One Year Award Amount: $400,000

f. Total Period of Performance Length: 2

g. Estimated Award Date: 09/30/2018

h. Cost Sharing and / or Matching Requirements: N No cost sharing or matching funds are required for this program. Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Part II. Full Text A. Funding Opportunity Description

Part II. Full Text

1. Background

a. Overview An estimated 500,000 children in the United States have blood lead levels (BLLs) at or above the CDC blood lead reference value. These children are at-risk for the intellectual and behavioral deficits and other adverse health effects caused by exposure to lead. The primary source of lead exposure to children is the home environment: some 38 million homes in the United States have lead-based paint hazards that can result in childhood lead poisoning. Low-income and minority children bear a disproportionate burden of lead exposure risk caused by lead hazards in the home environment. In addition, some areas of the United States report that as many as 35% of children identified with elevated BLLs are exposed to lead through sources other than lead-based paint in their homes (e.g., such as items decorated or made with lead).

Public health action is needed to support activities to monitor and prevent lead exposure in children, to address lead hazards, and to eliminate childhood lead poisoning as a public health problem.

b. Statutory Authorities This program is authorized under Sections 317(k)(2) and 317(A) of the Public Health Service Act, (42 U.S.C. Sections 247b(k)(2) and 247b-3(b)), as amended.

c. Healthy People 2020

The National Center for Environmental Health (NCEH) of CDC within HHS is committed to achieving the health promotion and disease prevention objectives of Healthy People 2020 found at: https://www.healthypeople.gov/. This NOFO is committed to the Healthy People 2020 lead-related goals of reducing: (1) blood lead levels above CDC's reference value, and (2) mean blood lead levels in young children, as well as disparities in blood lead levels based on race, ethnicity, and socioeconomic status, as public health concerns. This NOFO addresses the Healthy People 2020 topics of Maternal, Infant, and Child Health; Injury and Violence Preve ntion; and Environmental Health.

d. Other National Public Health Priorities and Strategies This NOFO also supports the National Prevention Strategy's Healthy and Safe Community Environments. Additional information can be found at: https:// www.surgeongeneral.gov/ prior ities/ prevention/ strategy/ healthy-and- safe-community-environments.html

e. Relevant Work The Lead Contamination Control Act of 1988 authorized the Centers for Disease Control and Prevention (CDC) to initiate program efforts to eliminate childhood lead poisoning in the United States. The CDC Childhood Lead Poisoning Prevention Program was created as a result of this act. From 1990 to 2012, CDC awarded funds to state and local health departments to support childhood lead poisoning prevention programs. In FY14 and FY17, CDC awarded 3-year funding for lead poisoning prevention strategic programmatic activities under CDC-RFA- EH14-1408PPHF14 and CDC-RFA-EH17-1701PPHF17, respectively. This NOFO directly builds on these programs and includes the same four strategic activities as CDC-RFA-EH17-

1707PPHF17.

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

https://www.healthypeople.gov/ https://www.healthypeople.gov/2020/topics-objectives/topic/maternal-infant-and-child-health https://www.healthypeople.gov/2020/topics-objectives/topic/injury-and-violence-prevention https://www.healthypeople.gov/2020/topics-objectives/topic/injury-and-violence-prevention https://www.healthypeople.gov/2020/topics-objectives/topic/environmental-health https://www.surgeongeneral.gov/priorities/prevention/strategy/healthy-and-safe-community-environments.html https://www.surgeongeneral.gov/priorities/prevention/strategy/healthy-and-safe-community-environments.html https://www.surgeongeneral.gov/priorities/prevention/strategy/healthy-and-safe-community-environments.html

i. Purpose This funding is intended to support activities to reduce childhood lead exposure and lead poisoning activities including: blood lead testing, surveillance, and targeted population-based interventions. Recipients will also be expected to demonstrate that processes are in place to identify lead-exposed children and link them to recommended services. Recipients will be expected to work closely with agencies, partners, and other stakeholders serving children to ensure that a comprehensive system of referral, case management, follow-up and evaluation is in place.

ii. Outcomes Recipients are expected to achieve and report the following short-term outcomes during the Period of Performance:

Increase the number of children less than 6 years (72 months) of age tested for blood lead.

Improve data usage that leads to a greater identification of geographic areas and populations at high-risk for lead exposed children.

Increase the ability to target interventions (e.g. education and outreach) to high-risk geographic areas and populations.

Increase the identification of children exposed to lead and link them to recommended services.

iii. Strategies and Activities Recipients must use childhood lead poisoning prevention and surveillance funding to accomplish the following four strategic activities.

1) Strengthen Blood Lead Level Testing In support of blood lead level testing, recipients should:

Develop and implement a plan for increasing blood lead testing of children less than 6 years (72 months) of age.

Develop and implement blood lead testing strategies, with special emphasis on achieving universal testing of Medicaid-enrolled children.

2) Strengthen Surveillance

Recipients are expected to implement a childhood lead poisoning surveillance system that can report to CDC quarterly on the number of children who are exposed to lead in housing, the number of houses that are identified with lead, and the nature and extent of lead in housing.

In addition recipients must:

Develop, implement, and maintain a blood lead surveillance system that will collect, compile, and track blood lead data and lead hazards data.

Develop and implement a blood lead data collection, data quality and dissemination plan.

Conduct analyses of surveillance data.

Establish and implement a surveillance reporting system and dissemination plan.

Include information on how data will be collected, evaluated, reported, shared with partners, and disseminated to the public.

3) Strengthen Population-based Interventions The following are population-based intervention activities that recipients should consider:

Develop and implement targeted population-based interventions. Educate public, partners, and stakeholders about lead-related issues.

Develop and conduct trainings for lead workforce, partners, and other stakeholders.

Develop and maintain collaborative relationships with community, local, and state partners and stakeholders to address priority challenges and opportunities.

To assist in the development and implementation of appropriate interventions, collected data shall integrate or interface with other:

Maternal child and environmental public health databases (e.g., immunization registries;

Adult Blood Lead Epidemiology and Surveillance [ABLES]; National Electronic Disease Surveillance System [NEDSS]; Environmental Public Health Tracking Network; Medicaid; and Special Supplemental Nutrition Program for Women, Infants and Children [WIC]);

State and local housing and environmental quality authorities; and Housing data including that for housing code enforcement agencies and publicly owned or subsidized properties and Housing and Urban Development (HUD) collaborative programs.

4) Strengthen processes to identify lead-exposed children and linkage to services The following activities should be considered in support of identifying lead-exposed children and linking them to services:

Provide technical support and subject matter expertise to systems that identify, refer, provide services to, and follow lead-exposed children.

Organize regular meetings with partners, stakeholders, and programs (e.g., early childhood education programs, social services, school systems, etc.) that can provide services to mitigate the effects of high blood lead levels.

Connect lead-exposed children to services.

Conduct education and outreach to parents and providers of lead-exposed children and those who are considered at-risk.

*The program should ensure that recipients adequately and appropriately inform the public that such education and outreach (mass communication campaigns) were supported with Federal dollars (if applicable).

*Recipients shall use education and outreach activities to raise awareness about lead-related issues and are explicitly prohibited from using Federal dollars for lobbying purposes.

i. Purpose This funding is intended to support activities to reduce childhood lead exposure and lead poisoning including strengthening: blood lead testing, surveillance, and targeted population-based interventions. Recipients will also be expected to demonstrate that processes are in place to identify lead-exposed children and link them to recommended services. Recipients will be expected to work closely with agencies and other stakeholders serving children to ensure that a system of blood lead testing, case management, referral, follow-up, surveillance/monitoring, and evaluation is in place.

ii. Outcomes Recipients are expected to achieve and report the following short-term outcomes during the Period of Performance:

1. Increase the number of children less than 6 years (72 months) of age tested for blood lead.

2. Improve data usage that leads to a greater identification of geographic areas and populations at high-risk for lead exposed children.

3. Increase the ability to target interventions (e.g. education and outreach) to high-risk geographic areas and populations.

4. Increase the identification of children exposed to lead and link them to recommended services.

iii. Strategies and Activities Applicants must use childhood lead poisoning prevention funding to accomplish the following four activities.

Strengthen Blood Lead Level Testing In support of blood lead level testing, applicants should:

Develop and implement a plan for increasing blood lead testing of children less than 6 years (72 months) of age.

Develop and implement blood lead testing strategies, with special emphasis on achieving universal testing of Medicaid-enrolled children.

Strengthen Surveillance Applicants are expected to implement a childhood lead poisoning surveillance system that can report to CDC quarterly on the number of children who are exposed to lead in housing, the number of houses that are identified with lead, and the nature and extent of lead in housing. In addition applicants must:

Develop, implement, and maintain a blood lead surveillance system that will collect, compile, and track blood lead data and lead hazards data.

Develop and implement a blood lead data collection, data quality and dissemination plan. Conduct analyses of surveillance data.

Establish and implement surveillance reporting system and dissemination plan. Include information on how data will be collected, evaluated, reported, shared with partners, and disseminated to the public.

Surveillance data collection efforts should maximally leverage existing tools and systems and should adhere to national data and technology standards to support interoperability of system-to-system data exchange.

Strengthen Population-based Interventions The following are population-based intervention activities that applicants should consider:

Develop and implement targeted population-based interventions. Educate public, partners, and stakeholders about lead-related issues.

Develop and conduct trainings for lead workforce, partners, and other stakeholders.

Develop and maintain collaborative relationships with community, local, and state partners and stakeholders to address priority challenges and opportunities.

To assist in the development and implementation of appropriate interventions, collected data shall integrate or interface with other:

Maternal child and environmental public health databases (e.g., immunization registries; Adult Blood Lead Epidemiology and Surveillance [ABLES]; National Electronic Disease Surveillance System [NEDSS]; Environmental Public Health Tracking Network; Medicaid; and Special Supplemental Nutrition Program for Women, Infants and Children [WIC]); State and local housing and environmental quality authorities; and Housing data including that for housing code enforcement agencies and publicly owned or subsidized properties and Housing and Urban Development (HUD) collaborative programs.

Strengthen processes to identify lead-exposed children and linkage to services The following activities should be considered in support of identifying lead-exposed children and linking them to services:

Provide technical support and subject matter expertise to systems that identify, refer, provide services to, and follow lead-exposed children.

Organize regular meetings with partners, stakeholders, and programs (e.g., early childhood education programs, social services, school systems, etc.) that can provide services to mitigate the effects of high blood lead levels.

Connect lead-exposed children to services.

Conduct education and outreach to parents and providers of lead-exposed children and those who are considered at-risk.

*The program should ensure that recipients adequately and appropriately inform the public that such education and outreach (mass communication campaigns) were supported with Federal dollars (if applicable).

*Applicants shall use education and outreach activities to raise awareness about lead-related issues and are explicitly prohibited from using Federal dollars for lobbying purposes.

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

Applicants should engage other CDC-funded programs in their jurisdictions, particularly those with a focus on child health and/or environmental health, and leverage opportunities to reach targeted populations, share databases, deliver services, and achieve outcomes expected under this NOFO. Applicants must file the MOU or MOA, as appropriate, name the file "MOUs/MOAs" and upload it as a PDF at grants.gov.

Examples of other CDC-funded programs include, but are not limited, to:

Environmental Public Health Tracking Program http://www.cdc.gov/nceh/tracking/ National Institute of Occupational Safety and Health?s Adult Blood Lead Epidemiology

Program (ABLES) https://www.cdc.gov/niosh/topics/ables/ State and local immunization and asthma programs and registries National Center for Birth Defects and Developmental Disabilities (NCBDDD) programs and registries Agency of Toxic Substances and Disease Registry's ATSDR's Partnership to Promote

Local Efforts to Reduce Environmental Exposure (APPLETREE) grantees (https://www.atsdr.cdc.gov/states/index.html) or other local/state/regional ATSDR activities or assessments (https://www.atsdr.cdc.gov/dro/index/html).

b. With organizations not funded by CDC:

Applicants should work with relevant organizations external to CDC that could extend their reach to targeted populations, interface with other databases, and help facilitate activities under this NOFO. Letters of support/Memorandums of Understanding/Memorandums of Agreement stating agreed upon area of collaboration from relevant state officials and others should be included in the application.

Examples of such organizations are:

U.S Department of Housing and Urban Development (HUD) Centers for Medicare and Medicaid Services (CMS) Special Supplemental Nutrition Program for Women, Infants and Children (WIC) U.S. Environmental Protection Agency (EPA) HRSA Title V recipients HRSA Federal Home Visiting Program HRSA Healthy Start Program Maternal and child health programs Early childhood education programs Community-based, nonprofit and/or faith-based organizations State and local health and housing agencies Private and public laboratories Hospitals and healthcare systems Academic institutions http://www.cdc.gov/nceh/tracking/ https://www.cdc.gov/niosh/topics/ables/

Accredited environmental health practitioners and their organizations

Strategies should be implemented for leveraging resources that include funds from other allowable federally funded programs and/or state, local, charity, nonprofit or for-profit entities, or internal agency resources.

Applicants are expected to create a capacity-building mechanism, with partners, that will provide training, education, technical support, mobilization, and consensus to improve the communities? ability to detect lead sources and identify risks and provide appropriate and timely interventions.

2. Target Populations The target population for this program is children less than 6 years (72 months) of age. Priority should be given to children disproportionately affected by lead exposures and lead poisoning, particularly those living in areas that include homes built before 1978, low-income or subsidized housing with suspected or known lead hazards, racial and ethnic minorities, and recent immigrants. Medicaid-enrolled children represent a high-risk target population.

a. Health Disparities Applicants should consider under-served populations, including tribal, disabled, and English speakers of other languages (ESOL), as well as other populations, to ensure they benefit from the applicants? childhood lead poisoning prevention activities.

iv. Funding Strategy Not Applicable.

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy Evaluation and progress reports Prepare a written assessment of the accomplishments, challenges and opportunities including a description of the problems encountered, lessons learned, potential improvements.

Strategies/Activities:

1) Strengthen Blood Lead Level Testing: Implement a plan for blood lead testing of children less than 6 years (72 months) of age.

Indicators for success: a completed blood lead testing plan that includes an emphasis on universal testing of Medicaid-enrolled children.

2) Strengthen Surveillance: Implement a surveillance reporting system and dissemination plan.

Include information on how data will be collected, evaluated, reported, shared with partners, and disseminated to the public.

Indicators for success: establishment and operation of an active ongoing sustainable childhood lead poisoning surveillance/tracking system in recipients? jurisdictions that collects person-specific and address-specific data, including multiple laboratory test results over various years and that assures the periodic screening of children who are exposed to lead; a completed surveillance plan outlining approaches for data collection, evaluation, timely reporting, and data sharing to both partners and the public.

Recipient's collection of sensitive data must be completed in accordance with all applicable privacy laws at both the state and federal level.

3) Strengthen Population-based Interventions: maintain collaborative relationships with community, local, and state partners and stakeholders to address priority childhood lead poisoning prevention challenges and opportunities.

Indicators for success: documentation of ongoing community and partners/stakeholder meetings; completed examples of lead prevention education and training materials;

implementation of a process that ensures data is received and used by federal agencies and public health officials to target actions to areas where the risk for childhood lead poisoning is the highest.

4) Strengthen processes to identify lead-exposed children and linkage to services:

Indicators for success: implementation of a process that identifies lead-exposed children, provides guidance for the referral and follow-up care of children, and evaluates the timeliness and efficacy of these activities.

Outcomes:

1) Increased numbers of children less than 6 years (72 months) of age tested for blood lead.

Indicators for success include:

Increase in the percentage of children less than 6 years (72 months) of age tested for blood lead from the previous reporting period;

Increase in the percentage of Medicaid-enrolled children less than 6 years (72 months) of age tested for blood lead since the previous reporting period.

Percent of Medicaid-enrolled one year-old children tested for blood lead levels during the reporting period

[calculation: (number of Medicaid-enrolled one year-old children tested for blood lead levels / total number of Medicaid-enrolled one year-old children in the jurisdiction)*100]

Percent of Medicaid-enrolled two year-old children tested for blood lead levels during the reporting period

[calculation: (number of Medicaid-enrolled two year-old children tested for blood lead levels / total number of Medicaid-enrolled two year-old children in the jurisdiction)*100]

Percent of all one and two year-old children (both Medicaid-enrolled and non- Medicaid-enrolled) tested for blood lead levels in the previous calendar year

[calculation: (number of children aged one and two years tested for blood lead in the previous calendar year / total number of children under three years of age in the jurisdiction in the previous calendar year)*100]

2) Improved availability and use of data that leads to improved identification of geographic areas and populations at high risk for lead Indicators for success include:

95% of Recipients' surveillance data received by CDC is free of errors and missing information;

Resources (e.g., GIS software) and data (e.g., blood lead surveillance, census, and tax assessor data) are used to analyze and report information;

The program is able to maintain 100% electronic reporting of blood lead data from laboratories.

Percent of laboratory-reported blood lead test results that are reported electronically [calculation: (number of laboratory-reported blood lead test results that are electronically reported / total number of laboratory-reported blood lead test results received during the reporting period)*100]

3) Increased ability to target population-based interventions to high-risk geographic areas and populations.

Indicators for success:

Community based partners (health care providers, grass roots organizations, nongovernment organizations [NGOs], others) and/or universities/colleges agree to participate in preparing for and assisting in population-based surveillance and targeted interventions.

Number of new partner organizations and institutions engaged in brainstorming, strategizing, planning, implementing, or evaluating interventions for lead poisoning prevention in targeted geographic areas during the reporting period Number of new partner organizations and institutions engaged in brainstorming, strategizing, planning, implementing, or evaluating interventions for lead poisoning prevention for targeted at-risk populations (to include low-income and immigrant/refugee children) during the reporting period Number of regularly scheduled and held meetings with partners and stakeholders during the reporting period Number of new memoranda of understanding or equivalent documents like memoranda of agreement and joint work plans - related to population-based childhood lead surveillance enhancement and targeted interventions for lead poisoning prevention developed and signed during the reporting period Number of new data-sharing agreements for enhanced population-based childhood lead surveillance developed and signed during the reporting period

4) Increased identification of lead-exposed children who receive appropriate linkages to recommended follow-up services.

Indicators for success:

Implementation of a process that identifies lead-exposed children, provides guidance for the referral and follow-up care of children with elevated BLLs, and evaluates the timeliness and efficacy of these activities.

Number of public health professionals and clinical providers who received guidance documents for follow-up care for children who are identified with elevated blood lead levels during the reporting period Percent of children less than 6 years (72 months) of age who are referred to or from your Program for recommended follow-up services within two weeks of a confirmed elevated blood lead test result during the reporting period

[calculation: (number of children with elevated blood lead levels referred for follow-up services / number of children with elevated blood lead levels)*100]

Percent of children less than 6 years (72 months) of age who received recommended follow-up services within two weeks of a referral for recommended follow-up services following a confirmed elevated blood lead test result during the reporting period

[calculation: (number of children with elevated blood lead levels who received referred follow-up services / number of children with elevated blood lead levels referred for follow-up services)*100]

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP), if applicable, for accuracy throughout the lifecycle of the project. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data; data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans.

For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additionalrequirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award, as described in the Reporting Section of this NOFO.

c. Organizational Capacity of Recipients to Implement the Approach The organizational capacity statement should describe how the applicant agency is organized to carry out the requirements of this announcement, the nature and scope of its work, and/or its capabilities. Applicants should include a detailed description of their experience in collecting, analyzing, and reporting data; implementing surveillance systems; targeting prevention activities to high risk areas; and managing programs and staff. They should also describe their working agreements, as well as letters of intent or contracts with partners.

Applicants should provide an organizational chart and curriculm vitae for key personnel. Key personnel must have the level of education, experience, and/or skills necessary to successfully implement and complete the project.

Additional information includes the following:

Organizational chart Curriculum vitae for existing key personnel (or job descriptions for planned key personnel) Indirect cost rate agreements Letters of support

The applicant must create a separate file for the noted items and must name the file "Organizational Chart","CVs/Resumes," "Indirect Cost Rate Agreements," and "Letters of Support" and upload to www.grants.gov.

d. Work Plan A work plan is a program management tool that provides program direction and guidance. It allows the project officer to monitor implementation of activities on progress on Period of Performance outcomes.

Applicants must have a work plan. No specific work plan template is required as long as it is clear how the components in the work plan crosswalk to the strategies and activities, outcomes, and evaluation performance measures presented in the logic model and the narrative sections of https://www.cdc.gov/grants/additionalrequirements/ar-25.html http://www.grants.gov/ this NOFO.

Applicants must provide a separate detailed work plan of no more than 5 pages to describe work to be conducted in the first year of this award. A high-level work plan of no more than 5 pages should be included separately to describe work to be conducted in year two of the award.

A sample work plan format is presented below.

Sample Work Plan Short-term Outcome 1:

Increased number of children less than 6 years (72 months) of age tested for blood lead

Strategies and Activities

Process Measure Status Baseline Target Responsible Position / Person

Target Completion Date

Develop and implement plan for blood lead testing of children

Plan for blood lead testing is completed

Completed N/A N/A Epidemiologist and Program Manager

09/29/2019

Develop and maintain collaborative relationships with community, local, and state partners and stakeholders to address priority challenges and opportunities

Number of community and partner/stakeholder meetings

In progress 1 4 Program Manager

09/29/2019

Develop and maintain collaborative relationships with community, local, and state partners and stakeholders

Number of memorandum of agreements (MOU) or signed

Not started 0 1 Program Manager

09/29/2019 to address priority challenges and opportunities

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

f. CDC Program Support to Recipients (THIS SECTION APPLIES ONLY TO

COOPERATIVE AGREEMENTS)

CDC and recipients share responsibility for successfully implementing the award and meeting identified outcomes. The following are potential areas of substantial CDC involvement, others may also be included:

i. CDC will provide Technical Assistance:

Provide subject matter expertise to support recipients in the development or enhancement and implementation of blood lead surveillance systems.

Provide subject matter expertise to support recipients in the development or enhancement of evaluation and performance measurement and program effectiveness.

Provide subject matter expertise to support recipients in the development or enhancement of work plans, program planning, and capacity building.

ii. CDC will support Information Sharing between Recipients:

Support information sharing of "best practices" and "lessons learned" through required annual recipient meetings and quarterly conference calls, and at other venues, as appropriate.

Provide access to information-sharing portals (e.g., sharepoint site).

Promote the use of "Success Stories" and other reports and publications.

iii. CDC will provide Additional Support:

Provide Healthy Homes and Lead Poisoning Software System (HHLPSS) at no cost to support recipients in deployment of the system and migration of data from other systems to HHLPSS.

Review the use of data and information collected to support development, enhancement or implementation of population-based interventions.

Provide guidance in implementing activities, and will identify major program issues, strategies, and priorities related to the cooperative agreement.

Promote collaboration with other federal, state, and local health; environmental; and housing agencies by initiating contacts, conference calls, and on-site visits to discuss programmatic issues.

Provide consultation and technical assistance regarding approaches used to links children to appropriate services.

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the CDC Program Support to Recipients Section.

2. Award Mechanism: UE2

3. Fiscal Year: 2018

4. Approximate Total Fiscal Year Funding: $5,000,000

5. Approximate Period of Performance Funding: $10,000,000

This amount is subject to the availability of funds.

Estimated Total Funding: $10,000,000

6. Approximate Period of Performance Length: 2 year(s)

7. Expected Number of Awards: 10

8. Approximate Average Award: $400,000 Per Budget Period

9. Award Ceiling: $500,000 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor: $200,000 Per Budget Period

11. Estimated Award Date: 09/30/2018

12. Budget Period Length: 12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total period of performance comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: Others (see text field entitled "Additional

Information on Eligibility" for clarification)

Additional Eligibility Category:

Government Organizations:

State governments or their bona fide agents (includes the District of Columbia)

Local governments or their bona fide agents

Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.

American Indian or Alaska Native tribal governments (federally recognized or state-recognized)

2. Additional Information on Eligibility Government Organizations: State, Local, Territorial (including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), or Tribal (federally recognized or state-recognized American Indian or Alaska Native) Governments, or their Bona Fide Agents.

Local Governments must represent a valid population size of at least 750,000 using U.S.

Census data or a 2011-2017 U.S. Census data update.

This NOFO is limited to State, Local, Territorial, or Tribal Governments, or their Bona Fide Agents that have not already received or been approved for funding under CDC-RFA-EH17-

1701PPHF17.

This Notice of Funding Opportunity (NOFO) is to support activities under the authority of:

Sections 317(k)(2) and 317(A) of the Public Health Service Act, (42 U.S.C. Sections 247b(k)(2) and 247b-3(b)), as amended. This NOFO supports activities related to lead poisoning prevention with a focus on using blood surveillance data to identify and implement appropriate interventions to populations at highest risk. Recipients must be able to assure that follow-up is provided for lead-exposed children. Therefore, recipients must have the authority in their jurisdiction(s) to govern, regulate, deliver, implement, and enforce policies, codes or requirements on childhood lead poisoning prevention that could involve Medicaid, housing, environmental regulation, medical laboratory, or consumer protection agencies. State, Local, Territorial, or Tribal governments, or their Bona Fide Agents, are the only entities with the broad authorities to achieve the mission of this NOFO.

3. Justification for Less than Maximum Competition Not Applicable

4. Cost Sharing or Matching Cost Sharing / Matching Requirement: No No cost sharing or matching funds are required for this program. Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

5. Maintenance of Effort Maintenance of effort is not required for this program.

D. Application and Submission Information

1. Required Registrations

An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number.

A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as a recipient. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the "Applicant Registration" option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up 1 Data

Universal Number System

(DUNS)

1. Click on http:// fedgov.dnb.com/ webform

2. Select Begin DUNS search/request process

3. Select your country or territory and follow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at (http:// fedgov.dnb.com/ webform) or call 1-866-705-5711 https://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://www.sam.gov/portal/public/SAM/ https://grants.gov/ https://www.grants.gov/ http://www.grants.gov https://www.grants.gov/ http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform

DUNS number 2 System for

Award Management

(SAM)

formerly Central Contractor Registration

(CCR)

1. Retrieve organizations DUNS number

2. Go to www.sam.gov and designate an E-Biz POC (note CCR username will not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fsd.gov/ fsd-gov/ home.do Calls:

866-606-8220

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to become an authorized organization representative (AOR)

2. Once the account is set up the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E- BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization

Same day but can take 8 weeks to be fully registered and approved in the system (note, applicants

MUST

obtain a

DUNS

number and

SAM

account before applying on grants.gov)

Register early!

Log into grants.gov and check AOR status until it shows you have been approved

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this notice of funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC OGS staff at 770-488- 2700 or e-mail OGS ogstims@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.

4. Submission Dates and Times If the application is not submitted by the deadline published in the NOFO, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant http://www.sam.gov https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do https://www.grants.gov mailto:ogstims@cdc.gov is authorized to submit a paper application, it must be received by the deadline provided by

OGS.

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: N/A

b. Application Deadline Due Date for Applications: 08/09/2018 , 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Date for Information Conference Call An informational conference call will occur on Tuesday, July 17, 2018, from 2 to 3 p.m. eastern standard time. Call-in information is 855-644-0229, conference ID 6530827 Updated details about the informational call will be posted at: https://www.cdc.gov/nceh/lead/

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov

Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

Risk Assessment Questionnaire Requirement CDC is required to conduct pre-award risk assessments to determine the risk an applicant poses to meeting federal programmatic and administrative requirements by taking into account issues such as financial instability, insufficient management systems, non-compliance with award conditions, the charging of unallowable costs, and inexperience. The risk assessment will include an evaluation of the applicant’s CDC Risk Questionnaire, located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, as well as a review of the applicant’s history in all available systems; including OMB-designated repositories of government-wide eligibility and financial integrity systems (see 45 CFR 75.205(a)), and other sources of historical information.